Concepedia
Statistics
Publications
7
Citations
274
H-Index
Active since
2015
Affiliations
University of Michigan(Current)
Michigan Center for Translational Pathology
The University of Texas MD Anderson Cancer Center
Elizabeth K. Ziemke is an author at University of Michigan specializing in oncology, medicine, and pharmacology.
Publications per year
2015–2024
Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6
Elizabeth K. Ziemke, Joseph S. Dosch, Joel D. Maust et al. · Clinical Cancer Research · 2015 · 96 citations · Full text
Medicine, Oncology, Pharmacology +17
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
Kavya Ramkumar, Soma Samanta, Anahita Kyani et al. · Nature Communications · 2016 · 74 citations · Full text
Medicine, Oncology, Pharmacology +13
Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
Joseph S. Dosch, Elizabeth K. Ziemke, Shanshan Wan et al. · Oncotarget · 2017 · 39 citations · Full text
Cancer Stem Cell Marker Phenotypes Are Reversible and Functionally Homogeneous in a Preclinical Model of Pancreatic Cancer
Joseph S. Dosch, Elizabeth K. Ziemke, Amrith Shettigar et al. · Cancer Research · 2015 · 25 citations · Full text
Medicine, Cell Biology, Oncology +17
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
Christopher E. Whitehead, Elizabeth K. Ziemke, Christy L. Frankowski-McGregor et al. · Nature Cancer · 2024 · 17 citations · Full text
1–5 of 7